# Vedolizumab Study With Inflammatory Bowel Disease Patients in Germany

> **NCT03375424** · — · UNKNOWN · sponsor: **Ced Service GmbH** · enrollment: 2500 (estimated)

## Conditions studied

- Inflammatory Bowel Diseases
- Treatment

## Interventions

- **BIOLOGICAL:** vedolizumab

## Key facts

- **NCT ID:** NCT03375424
- **Lead sponsor:** Ced Service GmbH
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-10-02
- **Primary completion:** 2019-04-30
- **Final completion:** 2024-04-30
- **Target enrollment:** 2500 (ESTIMATED)
- **Last updated:** 2017-12-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03375424

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03375424, "Vedolizumab Study With Inflammatory Bowel Disease Patients in Germany". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03375424. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*